Molecular imaging has experienced enormous advancements in the areas of imaging
technology, imaging probe and contrast development, and data quality, as well as machine …

Mass spectrometry imaging (MSI) has gone through a significant change over the last 3
years, the time span of this review. The predominant mass spectrometric method in …

Background Magnetic resonance spectroscopy (MRS) is an established tool for in-vivo
evaluation of the biochemical basis of human diseases. On one hand, such lucid depiction …

Abnormal choline metabolism continues to be identified in multiple cancers. Molecular
causes of abnormal choline metabolism are changes in choline kinase-α, ethanolamine …

Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS) has been classified as a
disease of the central nervous system by the WHO since 1969. Many patients carrying this …

Early detection of brain metastases and differentiation from other neuropathologies is
crucial. Although biopsy is often required for definitive diagnosis, imaging can provide useful …

Brain metastases are the most common intracranial tumors and occur in 20–40% of all
cancer patients. Lung cancer, breast cancer, and melanoma are the most frequent primary …

Gliomas are highly lethal tumours characterised by heterogeneous molecular features,
producing various metabolic phenotypes leading to therapeutic resistance. Lipid metabolism …

Hybrid PET/MR systems have rapidly progressed from the prototype stage to systems that
are increasingly being used in the clinics. This review provides an overview of …

This paper summarises the proceedings and discussions at the third annual workshop held
in Tübingen, Germany, dedicated to the advancement of the technical, scientific and clinical …